Why Biotech M&A Activity Could Heat Up In June – And Some Potential Acquisition Targets

  • by

Due in part to the American Society of Clinical Oncology’s big cancer conference, June is often a popular month for M&A activity in the biotech space – and with biotech stocks having fallen over the last couple of months, big pharma firms could be especially busy this June acquiring targets at the current low prices. For a number of possible acquisition targets, CLICK HERE.